According to a new market report published by Lucintel, the future of the tumor ablation market looks promising with opportunities in liver, lung, kidney, bone metastasis, prostate, and breast applications. The global tumor ablation market is expected to grow with a CAGR of 13% from 2020 to 2025. The major drivers for this market are growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, and sprouting number of hospitals, surgical, and ablation centers.
To download report brochure, please go to https://www.lucintel.com/tumor-ablation-market.aspx and click "download brochure" tab from the menu
Ablation is a treatment that destroys tumors without removing them. In this market, (radiofrequency (RF) ablation, microwave ablation, and cryo ablation are the major technologies. Lucintel forecasts that microwave ablation will remain the largest technology segment over the forecast period due to increasing private funding for novel product development of microwave ablation, its significant efficiency over other ablation technologies, and growing adoption of the microwave tumor ablation procedure among healthcare professionals to treat various cancers.
Within this market, surgical ablation will remain the largest mode of treatment segment over the forecast period due to a large number of minimally invasive surgical procedures performed in mature markets to treat various cancers, growing market awareness of the benefits of surgical ablation in emerging markets, and large proportion of cancer patients ineligible for surgical cancer treatment.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to rising inclination of patients towards minimally invasive procedures for cancer treatment and increasing government funding for cancer research.
AngioDynamics, Boston Scientific, Galil Medical, EDAP TMS, Healthtronics, Medtronic, Mermaid Medical, Misonix, Neuwave Medical, and Sonacare Medical are among the major suppliers in the global tumor ablation market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global tumor ablation market by technology, application, mode of treatment, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Tumor Ablation Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global tumor ablation market by technology, application, mode of treatment, end user, and region as follows:
By Technology [$M shipment analysis for 2014 – 2025]:
Radiofrequency (RF) Ablation
Microwave Ablation
Cryo Ablation
Other Technologies
By Application [$M shipment analysis for 2014 – 2025]:
Liver
Lung
Kidney
Bone Metastasis
Prostate
Breast
By Mode of Treatment [$M shipment analysis for 2014 – 2025]:
Percutaneous Ablation
Laparoscopic Ablation
Surgical Ablation
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others
By End User [$M shipment analysis for 2014 – 2025]:
Hospitals
Oncology Clinics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.